Latest California Healthline Stories
KHN’s ‘What the Health?’: Life After ‘Roe’ Is … Confusing
A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Journalists Explain the Effects of ‘Dobbs’ Decision and New Insurer Price Transparency Rules
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Cinco cosas que hay que saber sobre el aborto ahora que la Corte Suprema anuló Roe vs. Wade
Con esta decisión, los estados tienen la capacidad de establecer sus propias restricciones, por lo que el lugar en el que viven las personas determinará su nivel de acceso al aborto.
‘It’s Not a Haven’: With Limited Capacity for Abortion Care, Minnesota Clinics Brace for Influx
In Minnesota, where abortion rights are protected by the state’s constitution, legal doesn’t necessarily mean accessible. The state has just eight clinics that provide abortions, and both providers and advocates say resources available aren’t enough to meet demand as nearby states reduce abortion access.
Two Tennessee Abortion Clinics, Awaiting High-Court Ruling, Grapple With Uncertainty
The landmark Roe v. Wade decision could soon be overturned. Two Knoxville-based providers of reproductive health care wonder how — and if — they will continue to serve their patients.
KHN’s ‘What the Health?’: Taking a Shot at Gun Control
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
A Deep Dive Into the Widening Mortality Gap Across the Political Aisle
Research out this week examines how an area’s political environment can affect its mortality rate.
Misinformation Clouds America’s Most Popular Emergency Contraception
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation’s most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
Black Women Have Much at Stake in States Where Abortion Access May Vanish
For many women, abortion access has also meant better economic opportunities. But that could change in states that plan to ban most abortion access if the Supreme Court overturns Roe v. Wade. And those constraints could have a big impact on Black women. In Tennessee, Black women have abortions at more than four times the rate of white women.
Abortion Foes Take Political Risks by Dropping Exceptions for Rape, Incest, and Mother’s Life
Conservative states are moving to severely restrict abortions, and many are pressing for bans that provide no exception for cases of rape or incest or even to save the life of the mother. But public opinion polls suggest those limits could cause blowback.